JSI-1187-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JSI-1187-01, covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations [Phase 1]